Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NIH × Pain × Clear all

Phase

Phase NA 7 Phase 2 6 Phase 3 5 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 34 INDUSTRY 17 OTHER_GOV 2 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Anemia 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain 1 Neutropenia 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Hypothyroidism 1 Human Papillomavirus-Related Cervical Carcinoma 1 Hepatitis C, Chronic 1 Hepatitis C 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Fibrosis 1 Fatigue 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Diabetes Mellitus 1 Colonic Neoplasms 1

Interventions

Oxycodone 1 Morphine 1 Levopropoxyphene 1 Codeine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378937 2013-08-02

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

National Cancer Institute (NCI)

Phase 4 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡